Fortress Biotech Share Price Today
(NASDAQ: FBIO)

Name: Fortress Biotech Share Price Today (NASDAQ: FBIO) - Fortress Biotech Stock Price Live Quote | INDmoney
Brand: INDmoney
Rating: 4.7 (371551 reviews)

Fortress Biotech share price is $1.84 & ₹160.25 as on 5 Feb 2025, 2.30 'hrs' IST

$1.84

▲

0.02

(0.82%)

Market is closed - opens 8 PM, 05 Feb 2025

View live Fortress Biotech share price in Dollar and Rupees. Guide to invest in Fortress Biotech stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Fortress Biotech, along with analyst recommendations, forecasts, and comprehensive financials.

Fortress Biotech share price movements

Today's Low: $1.78
Today's High: $1.88
$1.84
3.26%
Downside
Day's Volatility :5.32%
Upside
2.13%
52 Weeks Low: $1.36
52 Weeks High: $2.89
$1.84
26.36%
Downside
52 Weeks Volatility :53.11%
Upside
36.33%

Fortress Biotech (FBIO) Returns

Period	Fortress Biotech Inc	Index (Russel 2000)
3 Months	3.69%	0.0%
6 Months	5.49%	0.0%
1 Year	6.1%	0.0%
3 Years	-93.76%	-11.7%

Fortress Biotech (FBIO) Key Statistics

in dollars & INR

Previous Close	$1.825
Open	$1.82
Today's High	$1.88
Today's Low	$1.78
Market Capitalization	$46.9M
Today's Volume	$271.3K
52 Week High	$2.89
52 Week Low	$1.355
Revenue TTM	$82.6M
EBITDA	$-90.3M
Earnings Per Share (EPS)	$-27.73
Profit Margin	-49.25%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-1739.64%

How to invest in Fortress Biotech Stock (FBIO) from India?

It is very easy for Indian residents to invest directly in Fortress Biotech from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Fortress Biotech stock in both Indian Rupees (INR) and US Dollars (USD). Search for Fortress Biotech or FBIO on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Fortress Biotech or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Fortress Biotech shares which would translate to 0.473 fractional shares of Fortress Biotech as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Fortress Biotech, in just a few clicks!

Returns in Fortress Biotech (FBIO) for Indian investors in Rupees

The Fortress Biotech stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

Fortress Biotech investment value today

Current value as on today

₹1,11,841

Returns

₹11,841

(+11.84%)

Returns from Fortress Biotech Stock

₹6,977 (+6.98%)

Dollar Returns

₹4,865 (+4.86%)

Indian investors sentiment towards Fortress Biotech (FBIO)

-58%

Period: Jan 5, 2025 to Feb 4, 2025. Change in 30 Days versus previous period

Search interest for Fortress Biotech Stock from India on INDmoney has decreased by -58% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Fortress Biotech

Vanguard Group Inc
2.26%
CAMBRIDGE Invest RESEARCH ADVISORS, INC.
2.01%
Rosalind Advisors, Inc.
1.82%
Shikiar Asset Management Inc
0.85%
Envestnet Asset Management Inc
0.67%
Geode Capital Management, LLC
0.61%

Analyst Recommendation on Fortress Biotech

Buy

90%Buy

9%Hold

0%Sell

Based on 11 Wall street analysts offering stock ratings for Fortress Biotech(by analysts ranked 0 to 5 stars)

Based on 11 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Fortress Biotech Stock (FBIO)

What analysts predicted

Upside of 660.87%

Target:

$14.00

Current:

$1.84

Insights on Fortress Biotech Stock (Ticker Symbol: FBIO)

Price Movement
In the last 3 years, FBIO stock has moved down by -93.6%
Decreasing Revenue
Revenue is down for the last 2 quarters, 14.89M → 14.62M (in $), with an average decrease of 1.8% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -10.94M → -12.86M (in $), with an average decrease of 17.5% per quarter
FBIO vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.6% return, outperforming this stock by 60.0%
FBIO vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 88.8% return, outperforming this stock by 182.4%
Price to Sales
ForFBIO every $1 of sales, investors are willing to pay $0.3, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $16.6 for every $1 of sales.

FBIO Fortress Biotech Financials in INR & Dollars

	FY18	Y/Y Change
Revenue	$26.9M	↓ 85.67%
Net Income	$-84.1M	↑ 25.83%
Net Profit Margin	-313.02%	↓ 277.37%

	FY19	Y/Y Change
Revenue	$36.6M	↑ 36.26%
Net Income	$-51.8M	↓ 38.43%
Net Profit Margin	-141.44%	↑ 171.58%

	FY20	Y/Y Change
Revenue	$45.6M	↑ 24.49%
Net Income	$-103.0M	↑ 98.78%
Net Profit Margin	-225.85%	↓ 84.41%

	FY21	Y/Y Change
Revenue	$68.8M	↑ 50.86%
Net Income	$-164.8M	↑ 60.05%
Net Profit Margin	-239.6%	↓ 13.75%

	FY22	Y/Y Change
Revenue	$75.7M	↑ 10.11%
Net Income	$-213.9M	↑ 29.78%
Net Profit Margin	-282.42%	↓ 42.82%

	FY23	Y/Y Change
Revenue	$84.5M	↑ 11.58%
Net Income	$-60.6M	↓ 71.65%
Net Profit Margin	-71.75%	↑ 210.67%

	Q2 FY23	Q/Q Change
Revenue	$17.4M	↑ 39.88%
Net Income	$-24.8M	↑ 12.05%
Net Profit Margin	-142.51%	↑ 35.39%

	Q3 FY23	Q/Q Change
Revenue	$34.8M	↑ 99.88%
Net Income	$-5.0M	↓ 79.64%
Net Profit Margin	-14.52%	↑ 127.99%

	Q4 FY23	Q/Q Change
Revenue	$19.9M	↓ 42.6%
Net Income	$-9.3M	↑ 83.92%
Net Profit Margin	-46.52%	↓ 32.0%

	Q1 FY24	Q/Q Change
Revenue	$13.0M	↓ 34.67%
Net Income	$-17.7M	↑ 91.09%
Net Profit Margin	-136.08%	↓ 89.56%

	Q2 FY24	Q/Q Change
Revenue	$14.9M	↑ 14.32%
Net Income	$-10.9M	↓ 38.26%
Net Profit Margin	-73.5%	↑ 62.58%

	Q3 FY24	Q/Q Change
Revenue	$14.6M	↓ 1.79%
Net Income	$-12.9M	↑ 17.53%
Net Profit Margin	-87.96%	↓ 14.46%

	FY18	Y/Y Change
Profit	$20.8M	↓ 21.32%

	FY19	Y/Y Change
Profit	$26.1M	↑ 25.73%

	FY20	Y/Y Change
Profit	$31.0M	↑ 18.81%

	FY21	Y/Y Change
Profit	$36.7M	↑ 18.39%

	FY22	Y/Y Change
Profit	$45.0M	↑ 22.51%

	FY23	Y/Y Change
Profit	$57.9M	↑ 28.65%

	Q2 FY23	Q/Q Change
Profit	$9.6M	↑ 60.85%

	Q3 FY23	Q/Q Change
Profit	$28.3M	↑ 194.45%

	Q4 FY23	Q/Q Change
Profit	$13.6M	↓ 52.14%

	Q1 FY24	Q/Q Change
Profit	$6.2M	↓ 54.15%

	Q2 FY24	Q/Q Change
Profit	$8.4M	↑ 34.45%

	Q3 FY24	Q/Q Change
Profit	$9.3M	↑ 11.84%

	FY18	Y/Y Change
Operating Cash Flow	$-98.8M	↑ 15.71%
Investing Cash Flow	$18.8M	↓ 146.8%
Financing Cash Flow	$50.6M	↓ 67.16%

	FY19	Y/Y Change
Operating Cash Flow	$-95.0M	↓ 3.93%
Investing Cash Flow	$20.1M	↑ 6.76%
Financing Cash Flow	$146.7M	↑ 189.67%

	FY20	Y/Y Change
Operating Cash Flow	$-83.7M	↓ 11.88%
Investing Cash Flow	$-7.2M	↓ 135.65%
Financing Cash Flow	$172.4M	↑ 17.51%

	FY21	Y/Y Change
Operating Cash Flow	$-116.5M	↑ 39.27%
Investing Cash Flow	$40.5M	↓ 665.52%
Financing Cash Flow	$149.0M	↓ 13.58%

	Q2 FY23	Q/Q Change
Operating Cash Flow	$-33.3M	↓ 22.97%
Investing Cash Flow	$-2.0M	↓ 59.22%
Financing Cash Flow	$-30.4M	↓ 236.93%

Fortress Biotech Technicals Summary

Sell

Neutral

Buy

Fortress Biotech is currently in a neutral trading position according to technical analysis indicators.

Fortress Biotech (FBIO) Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Fortress Biotech Inc	-19.25%	5.49%	6.1%	-93.76%	-95.28%
Biontech Se	-0.32%	51.19%	24.81%	-30.66%	288.02%
Regeneron Pharmaceuticals, Inc.	-6.9%	-37.55%	-28.89%	7.15%	74.63%
Vertex Pharmaceuticals Incorporated	16.87%	0.96%	13.03%	93.36%	95.94%
Alnylam Pharmaceuticals, Inc.	17.76%	5.53%	59.46%	84.7%	118.8%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Fortress Biotech Inc	NA	NA	-0.1	-3.1	-17.4	-0.36	NA	0.79
Biontech Se	160.8	NA	0.04	-3.32	-0.02	-0.01	NA	79.73
Regeneron Pharmaceuticals, Inc.	16.64	16.64	1.08	44.92	0.17	0.07	NA	272.04
Vertex Pharmaceuticals Incorporated	32.84	NA	1.21	0.49	-0.03	0.12	NA	60.65
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.18	-15.01	-0.03	NA	0.25

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Fortress Biotech Inc	Buy	$46.9M	-95.28%	NA	-49.25%
Biontech Se	Buy	$29.7B	288.02%	160.8	-15.36%
Regeneron Pharmaceuticals, Inc.	Buy	$74.0B	74.63%	16.64	33.61%
Vertex Pharmaceuticals Incorporated	Buy	$118.9B	95.94%	32.84	-4.51%
Alnylam Pharmaceuticals, Inc.	Buy	$35.0B	118.8%	NA	-15.86%

About Fortress Biotech

Fortress Biotech, Inc., a biopharmaceutical company, develops dermatology, pharmaceutical, and biotechnology products in the United States. The company markets dermatology products, such as Qbrexza a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane capsules for severe recalcitrant nodular acne; Amzeeq for severe acne vulgaris; Zilxi, a topical foam; Exelderm cream and solution for topical use; Targadox an oral doxycycline drug for adjunctive therapy for severe acne; Luxamend; sulconazole nitrate cream and solution for tinea cruris and tinea corporis; and doxycycline hyclate tablet. It also develops late stage product candidates, such as intravenous Tramadol for the treatment of post-operative acute pain; CUTX-101, an injection for the treatment of Menkes disease; Cosibelimab for metastatic cancers; Olafertinib for the treatment of patients with EGFR mutation-positive NSCLC; CAEL-101 for the treatment of amyloid light chain amyloidosis; Triplex vaccine for cytomegalovirus; and DFD-29 for the treatment of rosacea. The company's early stage product candidates include Dotinurad for gout; MB-106 for B-cell non-hodgkin lymphoma; MB-101 for glioblastoma; MB-108 for recurrent GBM; MB-109 for refractory glioblastoma; AJ201, an androgen receptor degradation enhancer; BAER-101, a positive allosteric modulator; MB-117 for newly diagnosed x-linked severe combined immunodeficiency; and MB217 for previously transplanted; and MB-110 for RAG1 severe combined immunodeficiency. Its preclinical product candidates comprise Mayo Clinic In Vivo CAR T Platform Technology; AAV-ATP7A gene therapy; AVTS-001 gene therapy; CK-103 BET inhibitor; CEVA-D and CEVA-102; CK-302, an anti-GITR; CK-303, an anti-CAIX; and oligonucleotide platform. The company was formerly known as Coronado Biosciences, Inc. and changed its name to Fortress Biotech, Inc. in April 2015. Fortress Biotech, Inc. was incorporated in 2006 and is based in Bay Harbor Islands, Florida.

Organization	Fortress Biotech
Employees	186
CEO	Dr. Lindsay Allan Rosenwald
Industry	Health Technology

Management People of Fortress Biotech

Name	Title
Dr. Lindsay Allan Rosenwald	Executive Chairman, President & CEO
Mr. David Jin	CFO & Head of Corporate Development
Mr. Michael S. Weiss Esq.	Executive Vice Chairman of Strategic Development & Director
Mr. Samuel Berry	General Counsel & Corporate Secretary
Dr. George C. Avgerinos	Senior Vice President of Biologics Operations

Important FAQs about investing in FBIO Stock from India :

What is Fortress Biotech share price today?

Fortress Biotech share price today stands at $1.84, Open: $1.82 ; Previous Close: $1.83 ; High: $1.88 ; Low: $1.78 ; 52 Week High: $2.89 ; 52 Week Low: $1.36.

The stock opens at $1.82, after a previous close of $1.83. The stock reached a daily high of $1.88 and a low of $1.78, with a 52-week high of $2.89 and a 52-week low of $1.36.

Can Indians buy Fortress Biotech shares?

Yes, Indians can invest in the Fortress Biotech (FBIO) from India.

With INDmoney, you can buy Fortress Biotech at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Fortress Biotech at zero transaction cost.

How can I buy Fortress Biotech shares from India?

It is very easy to buy Fortress Biotech from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Fortress Biotech (FBIO) be purchased?

Yes, you can buy fractional shares of Fortress Biotech with INDmoney app.

What are the documents required to start investing in Fortress Biotech stocks?

To start investing in Fortress Biotech, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.